<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00740012</url>
  </required_header>
  <id_info>
    <org_study_id>Glucoday BL</org_study_id>
    <nct_id>NCT00740012</nct_id>
  </id_info>
  <brief_title>Glycemic Rises After Waking Up In Response To An Alarm Clock In Type 1-Diabetic Patients Analysed With Continuous Glucose Monitoring (GlucoDay®)</brief_title>
  <official_title>Blutzucker-Nachtprofile Mit Wecker Und Selbstmessungen gegenüber Fremdmessungen Durch Spezialisiertes Pflegepersonal: Eine Analyse Mittels Kontinuierlichem Glukose-Monitoring (Glucoday®)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Diabeteszentrum Bad Lauterberg im Harz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Berlin-Chemie Menarini</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Diabeteszentrum Bad Lauterberg im Harz</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study hypothesis: Waking up in response to an alarm clock may evoke a stress reaction that
      leads to rising glucose concentrations.

      The purpose of this study was to prove this hypothesis with continuous glucose monitoring
      over three nights.

      Night (a) with an alarm clock set at 2 h intervals for glucose self monitoring,

      Night (b) with a nurse performing blood glucose determinations, and

      Night (c) with the patients left undisturbed.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To provide nocturnal glucose control in patients with type 1 diabetes is a therapeutic
      challenge. Nocturnal glucose profiles are an important tool to secure adequate glycemic
      control during the night. Often, patients are asked to perform self-monitoring with the help
      of an alarm clock. Such a recommendation depends on the accuracy of glucose concentrations
      determined this way. We hypothesized that alarm clocks may trigger a stressful arousal that
      might be accompanied by rises in glucose concentrations, consecutively leading to nocturnal
      glucose profiles that are not representative for undisturbed conditions.

      We want to prove this hypothesis with 30 patients over three nights.

      Night (a) with an alarm clock set at 2 h intervals (midnight, 2 a.m., 4a.m. and 6:45 a.m) for
      glucose self monitoring,

      Night (b) with a nurse performing blood glucose determinations at the 2 h intervals
      (midnight, 2 a.m., 4a.m. and 6:45 a.m), and

      Night (c) with the patients left undisturbed.

      All the patients are going to use a continuous glucose monitor and half of the patients
      (uneven numbers) are going to have an indwelling venous cannula during night (a) and (b.

      During night (a) and (b) 5-7 minutes after the scheduled times for glucose measurements the
      doctoral candidate is going to take the pulse, another capillary blood sample for a
      laboratory glucose determination (EBIOS, Eppendorf, Hamburg, Germany). Also the doctoral
      candidate is going to take a venous blood sample in half of the patients (uneven numbers),
      blood from the indwelling venous cannula for the determination of epinephrine,
      norepinephrine, cortisol, glucagon, growth hormone, and prolactin (determined by specific
      immunoassays at Biocientia laboratories, Jena, Germany).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2007</start_date>
  <completion_date type="Actual">September 2008</completion_date>
  <primary_completion_date type="Actual">September 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glucose (continuous glucose monitoring)</measure>
    <time_frame>10 pm, midnight, 2 am, 4 am and 6:45 am continous glucose monitoring during three nights</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hormones (norepinephrine, cortisol, glucagon, growth hormone, prolactin), Pulse, Blood glucose</measure>
    <time_frame>22 pm, midnight, 2 am, 4 am, 6:45 am</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">32</enrollment>
  <condition>Stress</condition>
  <condition>Type 1 Diabetes</condition>
  <arm_group>
    <arm_group_label>Even, low numbers</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>They start with a alarm- clock night. No venous blood drawing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Even, high numbers</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>They start with a nurse performing blood glucose determination. No venous blood drawing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Uneven, low numbers</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>They start with an alarm- clock night and have venous blood drawing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Uneven, high numbers</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>They start with a nurse performing blood glucose determination and have venous blood drawing.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Continuous glucose monitoring</intervention_name>
    <description>Glucoday S (microdialysis system). Continuous glucose monitoring all three nights</description>
    <arm_group_label>Even, low numbers</arm_group_label>
    <arm_group_label>Even, high numbers</arm_group_label>
    <arm_group_label>Uneven, low numbers</arm_group_label>
    <arm_group_label>Uneven, high numbers</arm_group_label>
    <other_name>Gluco Day S (Menarini Diagnostics)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>alarm- clock intervention, patient perform blood glucose self monitoring</intervention_name>
    <description>Alarm clock intervention at midnight, 2 a.m., 4 a.m. and 6:45 a.m.</description>
    <arm_group_label>Even, low numbers</arm_group_label>
    <arm_group_label>Even, high numbers</arm_group_label>
    <arm_group_label>Uneven, low numbers</arm_group_label>
    <arm_group_label>Uneven, high numbers</arm_group_label>
    <other_name>Ordinary alarm clock</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>nurse intervention</intervention_name>
    <description>Nurse intervention: gently drawing capillary sample (blood glucose)at midnight, 2 a.m., 4 a.m. and 6:45 a.m. .</description>
    <arm_group_label>Even, low numbers</arm_group_label>
    <arm_group_label>Even, high numbers</arm_group_label>
    <arm_group_label>Uneven, low numbers</arm_group_label>
    <arm_group_label>Uneven, high numbers</arm_group_label>
    <other_name>professional night nurses</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Taking the patients pulse</intervention_name>
    <description>In nights (a) and (b) the doctoral candidate takes the patients pulse 5-7 minutes after the alarm clock or the nurse.</description>
    <arm_group_label>Even, low numbers</arm_group_label>
    <arm_group_label>Even, high numbers</arm_group_label>
    <arm_group_label>Uneven, low numbers</arm_group_label>
    <arm_group_label>Uneven, high numbers</arm_group_label>
    <other_name>Pulse measurment</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Venous blood drawing</intervention_name>
    <description>Venous blood drawing for the determination of epinephrine, norepinephrine, cortisol, glucagon, growth hormone, and prolactin (determined by specific immunoassays at Biocientia laboratories, Jena, Germany) (6-10 minutes after midnight, 2 a.m., 4 a.m. and 6:45 a.m.)in night (a) and (b)</description>
    <arm_group_label>Uneven, low numbers</arm_group_label>
    <arm_group_label>Uneven, high numbers</arm_group_label>
    <other_name>venous blood drawing from an intravenous catheter</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Other capillary sample</intervention_name>
    <description>5-7 minutes after the alarm clock or the nurse the doctoral candidate takes another capillary sample for a laboratory glucose determination (EBIOS, Eppendorf, Hamburg, Germany) analyzer.</description>
    <arm_group_label>Even, low numbers</arm_group_label>
    <arm_group_label>Even, high numbers</arm_group_label>
    <arm_group_label>Uneven, low numbers</arm_group_label>
    <arm_group_label>Uneven, high numbers</arm_group_label>
    <other_name>laboratory method (EBIOS, Eppendorf, Hamburg, Germany)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 1 Diabetic patients (diagnosed longer than 2 years)

          -  HBA1c 5,0 - 9,5 %

          -  Age 18-75 years

          -  Hospitalized patients

          -  Male or female, if female exclusion of pregnancy or secure contraception

          -  Body-Mass-Index 19-40 kg/m²

          -  Patient is elucidated

          -  Patients agreement

        Exclusion Criteria:

          -  Type 2-Diabetic patients or other forms of diabetes beside type 1 diabetes, diagnosed
             after the guidelines of the Deutsche Diabetes Gesellschaft

          -  HbA1c &lt; 5,0 % or &gt; 9,5 %

          -  A severe hypoglycemia with unconsciousness within the last 2 month

          -  Body-Mass-Index &lt; 19 or &gt; 40 kg/m²

          -  No patient agreement

          -  Pregnancy (positive pregnancy test) or unsecured contraception.

          -  Agina pectoris or acute myocardial infarct, as continuous problem

          -  Inadequate treated arterial hypertension &gt; 160 mmHg systolic and/or &lt; 95 mmHg
             diastolic

          -  Active tumor disease

          -  Anemia hemoglobin &lt; 11,5 g/dl

          -  Treatment with steroids, sedative or anesthetics

          -  Infection/fewer &gt; 37.5 °C

          -  Renal- malfunction (serum- creatinine &gt; 1.5 mg/dl)

          -  Liver- malfunction (GPT and AP &gt; double of upper- limit)

          -  Alcohol or drug abuse

          -  Sleep disorder

          -  Participation in clinical studies within the last 3 month

          -  Other significant health dysfunctions, which would affect the outcome of this study

          -  Incapable to conform the requirements of the protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael A. Nauck, professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Diabeteszentrum Bad Lauterberg</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Diabeteszentrum Bad Lauterberg im Harz</name>
      <address>
        <city>Bad Lauterberg</city>
        <state>Lower Saxony</state>
        <zip>37431</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Berndt C, Köthe L, Nawrodt B, Mraz B, Patzelt-Bath A. Glycaemic rises after waking up in response to an alarm clock during the night in type 1 diabetic patients can be avoided by experienced nurses drawing blood in a hospital setting as shown by continuous glucose monitoring (GlucoDayR) (abstract 14). Diabetologia 51 (Suppl. 1): S 12</citation>
  </results_reference>
  <verification_date>September 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 20, 2008</study_first_submitted>
  <study_first_submitted_qc>August 21, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 22, 2008</study_first_posted>
  <last_update_submitted>September 25, 2008</last_update_submitted>
  <last_update_submitted_qc>September 25, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 29, 2008</last_update_posted>
  <responsible_party>
    <name_title>Prof. Dr. Michael Nauck</name_title>
    <organization>Diabeteszentrum Bad Lauterberg</organization>
  </responsible_party>
  <keyword>Nocturnal glucose profiles</keyword>
  <keyword>continuous glucose profiles</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

